Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20K Buy
6,900
+5,600
+431% +$20.2K ﹤0.01% 1107
2026
Q2
$5.37K Buy
+1,300
New +$5.74K ﹤0.01% 1178
2026
Q1
– Sell
-2,000
Closed -$6.82K – 1341
2025
Q4
$6.82K Buy
+2,000
New +$9.7K ﹤0.01% 953

Other funds holding LFMD

All Options USA's LFMD Position: Q3 2026 in Review

All Options USA reduced its LifeMD (LFMD) stake by 46% in Q3 2026, selling an estimated $61.9K and leaving 19,968 shares worth $57.9K. The position accounts for 0.01% of the portfolio, ranked #876.

All Options USA first reported a position in LFMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $153K in Q2 2026. 94 funds tracked by Wall St. Rank hold LFMD as of Q3 2026.

  • All Options USA held 19,968 shares of LifeMD worth $57.9K as of Q3 2026.
  • All Options USA sold 17,198 LifeMD shares in Q3 2026, an estimated $61.9K.
  • LifeMD made up 0.01% of All Options USA's portfolio in Q3 2026, its #876 holding.
  • All Options USA first reported a position in LifeMD in Q4 2025 and has held it in 4 quarters since.
  • All Options USA's LifeMD position peaked at $153K in Q2 2026.
  • 94 funds tracked by Wall St. Rank held LifeMD as of Q3 2026.

Based on All Options USA's 13F filing for Q3 2026, filed 12 Nov 2026.